{"id":"d537c012-b7aa-4228-969b-b31e8ef7c43d","kind":"news","code":"d537c012-b7aa-4228-969b-b31e8ef7c43d","name":"cytoReason raises USD 80 million in strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"cytoReason完成8000万美元战略投资融资","eventDate":"2024-07-18T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:13.219Z","englishUpdatedAt":"2026-10-15T17:20:00.058Z","reviewedAt":"2026-10-15T17:20:00.058Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5eab5a1aa9aa0ec81ef053a5c3c43a64a2261db7adec1d7b0f6ccb91c732b2ac","companyId":"5d107c78-a2e8-409e-9b53-5aa8d34c431a","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"69d3b330-4676-467d-846b-bc919fe3fb57","kind":"institutions","code":"UB-I5386","name":"Huiruizhiyao","nameBasis":"transliterated","summary":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","description":"Huiruizhiyao is a Chinese corporate strategic investment entity, investing industrial capital in growth-stage and mature companies.","country":null,"category":null,"originalName":"辉瑞制药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:29.534Z","englishUpdatedAt":"2026-10-15T18:43:03.653Z","reviewedAt":"2026-10-15T18:43:03.653Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"19d44125e90f4bdb356673c54854b5a6682643e7c06a0dc6965d465857d2bb5e","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/huiruizhiyao"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":"United States","category":null,"originalName":"NVIDIA","eventDate":null,"website":"https://www.nvidia.com/","sourceUpdatedAt":"2026-10-20T17:00:11.935Z","englishUpdatedAt":"2026-10-20T18:27:03.389Z","reviewedAt":"2026-10-20T18:27:03.389Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"e8677d0b441a42e930c15aa85b4c132b1dfeda4d489cf27951b3801c5aec760b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"218fad8b-352a-457a-b0bc-2c4a2caa9e6b","kind":"institutions","code":"UB-I6427","name":"OurCrowd","nameBasis":"original-brand","summary":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","description":"OurCrowd is a U.S. venture capital firm, investing primarily in seed- to growth-stage technology companies.","country":"United States","category":null,"originalName":"OurCrowd","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T02:00:21.123Z","englishUpdatedAt":"2026-10-20T18:26:49.524Z","reviewedAt":"2026-10-20T18:26:49.524Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"fc83f1d35dde378a319a6f0f6f364eb6f744cfbb5e7aef2ed3abc156984909db","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ourcrowd"},{"id":"c1b63651-6424-4490-8b22-296da7acc1c4","kind":"institutions","code":"UB-I5493","name":"Saimofei","nameBasis":"transliterated","summary":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","description":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","country":null,"category":null,"originalName":"赛默飞","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.525Z","englishUpdatedAt":"2026-10-15T18:26:25.115Z","reviewedAt":"2026-10-15T18:26:25.115Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f3dad43b23fb17595981da5749569b34d42b855b9ab40a1ad7864e75edeefd30","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/saimofei"},{"id":"5d107c78-a2e8-409e-9b53-5aa8d34c431a","kind":"companies","code":"UB-C7813","name":"cytoReason","nameBasis":"source-english","summary":"","description":"","country":"Israel","category":null,"originalName":"cytoReason","eventDate":null,"website":"https://www.cytoreason.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:24:40.775Z","reviewedAt":"2026-10-20T18:24:40.775Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"335dc28cf6a044ad05db209575d6a970a1c55a7311280ab66b065cb48cd4d0e5","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/cytoreason"}],"path":"/news/d537c012-b7aa-4228-969b-b31e8ef7c43d","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"cytoReason","path":"/companies/cytoreason"}},"canonical":"https://uniquebase.ai/news/d537c012-b7aa-4228-969b-b31e8ef7c43d"}